company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9316000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,7000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,368000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,52900000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,70000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3417000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,,totalassets,Total Assets,=,debit,usd,56387000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6239000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,156000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,353000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6748000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2651000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2651000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9399000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,398610000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-351265000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,46988000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,46988000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,46988000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q2,,2011-06-30,2011-08-08 17:01:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,56387000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37834000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9263000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,64000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,804000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,47965000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,72000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3417000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,,totalassets,Total Assets,=,debit,usd,51454000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9262000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,156000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,503000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9921000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2639000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2639000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12560000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,400763000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-361512000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,38894000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,38894000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,38894000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2011.0,Q3,,2011-09-30,2011-11-04 17:01:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,51454000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21700000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9212000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,67000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,524000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,31503000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,59000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3417000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,,totalassets,Total Assets,=,debit,usd,34979000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9559000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,178000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9737000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2663000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2663000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12400000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,401937000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-379001000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,22579000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,22579000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,22579000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q1,,2012-03-31,2012-05-09 10:24:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,34979000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21100000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,6012000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,38000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,190000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,27340000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,51000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,209000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3417000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,,totalassets,Total Assets,=,debit,usd,30808000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8865000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,418000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9283000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9294000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,402376000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-380505000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,21514000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,21514000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,21514000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q2,,2012-06-30,2012-08-08 16:30:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,30808000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20248000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,558000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,20806000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,59000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,198000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3406000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,,totalassets,Total Assets,=,debit,usd,24271000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,562000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7687000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7687000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,402921000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-385980000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,16584000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,16584000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,16584000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2012.0,Q3,,2012-09-30,2012-11-08 17:01:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,24271000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87343000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1744000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,89087000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,91000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,163000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3371000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,,totalassets,Total Assets,=,debit,usd,92549000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8454000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,202000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8656000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,24000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8680000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,478889000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-394663000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,83869000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,83869000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,83869000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q1,,2013-03-31,2013-05-08 16:36:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,92549000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55879000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,24294000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,226000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1254000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,81653000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,79000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,163000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3371000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,,totalassets,Total Assets,=,debit,usd,85103000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11398000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,422000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11820000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,12000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11832000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,479649000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-406021000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,73271000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,73271000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73271000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q2,,2013-06-30,2013-08-02 16:04:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85103000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67738000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,156000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3671000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,71565000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,71000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,221000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3429000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,,totalassets,Total Assets,=,debit,usd,75065000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15863000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,632000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16495000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16495000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,480599000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-421672000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,58570000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,58570000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,58570000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2013.0,Q3,,2013-09-30,2013-11-04 17:01:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,75065000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,105257000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,49665000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,195000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1245000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,156362000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,538000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,217000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3425000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,,totalassets,Total Assets,=,debit,usd,160325000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15955000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,414000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16369000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,41000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16410000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,597142000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-452870000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,144629000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,143915000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,143915000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q1,,2014-03-31,2014-05-08 16:02:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,160325000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,91994000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,44991000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,136000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1155000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138276000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1048000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,362000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3570000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,,totalassets,Total Assets,=,debit,usd,142894000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17226000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1285000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18511000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,78000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,78000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18589000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,599946000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-475284000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,124305000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,124305000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,124305000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q2,,2014-06-30,2014-08-07 17:03:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142894000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,84132000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,34101000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,151000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,918000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2743000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,122045000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1363000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,292000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3500000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,,totalassets,Total Assets,=,debit,usd,126908000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2987000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28125000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,75000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,75000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,28200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,609638000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-510573000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,98708000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,98708000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,98708000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2014.0,Q3,,2014-09-30,2014-11-06 17:05:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,126908000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,168836000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1283000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,27242000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3388000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,200749000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1455000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,307000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3515000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,,totalassets,Total Assets,=,debit,usd,205719000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,33069000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,714000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2573000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36356000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,722000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,99000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,821000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,37177000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,747496000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-578597000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,169256000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,168542000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,168542000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q1,,2015-03-31,2015-05-04 16:34:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,205719000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,131289000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1913000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1438000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,34031000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2769000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,171440000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1412000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1099000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4307000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,,totalassets,Total Assets,=,debit,usd,177159000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1529000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4060000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,244000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27337000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,745000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1938000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2683000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,30020000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,752970000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-605474000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,147853000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,147139000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,147139000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q2,,2015-06-30,2015-08-06 17:02:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,177159000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,102208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1913000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2628000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,36705000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4289000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,147743000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2604000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1099000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4307000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,,totalassets,Total Assets,=,debit,usd,154654000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,23935000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1985000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4439000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,244000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30603000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,767000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2214000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2981000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33584000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,757646000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-636219000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,121070000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,121070000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,121070000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2015.0,Q3,,2015-09-30,2015-10-29 17:16:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,154654000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,170531000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,637000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4325000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,42198000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2519000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,220210000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5014000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1100000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4308000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,,totalassets,Total Assets,=,debit,usd,229532000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13748000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3718000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3580000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,49030000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,70076000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,106521000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,810000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2730000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,110061000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,180137000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,764719000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-714967000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,49395000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,49395000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,49395000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q1,,2016-03-31,2016-04-28 16:05:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,229532000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,155796000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5101000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,39671000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2152000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,202720000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4755000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1024000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4232000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,,totalassets,Total Assets,=,debit,usd,211707000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14713000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3358000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5075000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,259000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,23405000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,830000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2618000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128448000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,151853000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,819829000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-759618000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59854000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59854000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59854000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q2,,2016-06-30,2016-08-05 17:31:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,211707000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,132172000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,24313000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3469000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,159954000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4439000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1024000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4232000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,,totalassets,Total Assets,=,debit,usd,168625000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13115000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4923000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,244000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18282000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,850000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2504000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128354000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,146636000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,823660000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-801314000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,21989000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,21989000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,21989000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2016.0,Q3,,2016-09-30,2016-11-09 07:18:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,168625000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90909000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6153000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,12592000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9653000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,119307000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3982000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1199000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4407000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,,totalassets,Total Assets,=,debit,usd,127696000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21756000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,368000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22124000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,890000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2207000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128097000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,150221000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,835946000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-858114000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-22525000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-22525000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-22525000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q1,,2017-03-31,2017-05-04 16:36:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,127696000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,140527000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8459000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,18085000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,8636000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,175707000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4172000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1102000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4310000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,,totalassets,Total Assets,=,debit,usd,184189000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,30146000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,375000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30521000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,909000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2110000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,128019000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,158540000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,970617000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-944611000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,25649000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,25649000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,25649000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q2,,2017-06-30,2017-07-27 07:20:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,184189000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,113999000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9198000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,26010000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,15571000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,164778000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4698000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1138000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4346000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,,totalassets,Total Assets,=,debit,usd,173822000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,36538000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,382000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36920000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,930000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2010000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,127940000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,164860000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,977428000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-968109000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,8962000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,8962000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,8962000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2017.0,Q3,,2017-09-30,2017-11-07 08:50:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,173822000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60087000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12889000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,35443000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,11130000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,119549000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4347000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13018000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,16226000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,,totalassets,Total Assets,=,debit,usd,140122000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,44522000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,396000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44918000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,125000000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1812000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,126812000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,171730000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,988567000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1019818000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-31608000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-31600000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-31600000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q1,,2018-03-31,2018-05-10 16:23:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,140122000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49458000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15430000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,48584000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,12142000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,125614000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4097000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12732000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,15940000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,,totalassets,Total Assets,=,debit,usd,145651000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,54647000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,402000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,55049000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,130088000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1706000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,131794000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,186843000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1000501000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1041336000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-41192000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-41200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-41200000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q2,,2018-06-30,2018-08-09 16:15:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,145651000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,41146000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14606000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,58736000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,11924000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,126412000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3846000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3208000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,18318000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21526000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,,totalassets,Total Assets,=,debit,usd,151784000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,56691000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,409000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57100000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,147302000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1601000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,148903000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,206003000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1004469000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1058331000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-357000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-54219000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-54219000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-54219000.0
Keryx Biopharmaceuticals Inc,KERX,,0001114220,2018.0,Q3,,2018-09-30,2018-11-08 17:32:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,151784000.0
